6505--Simvastatin Tablets (VA-26-00009813)

Closed Solicitation Posted

This opportunity was awarded. See the award notice from .

Solicitation number
36E79725R0066
Agency
Responses due
Set-aside
No set-aside

Opportunity facts

Notice details come from SAM.gov. Updated .

About this opportunity

The Department of Veterans Affairs National Acquisition Center is seeking offers for Simvastatin Tablets across 13 line items featuring various strengths (5mg, 10mg, 20mg, 40mg, and 80mg) and package sizes (45, 90, and 1,000 tablets per bottle). Offerors must provide pricing for all line items and option years, with prices inclusive of a 0.5% Cost Recovery Fee, and submit a unique 11-digit National Drug Code (NDC) number along with evidence of FDA approval and current Good Manufacturing Practices (cGMP) compliance. The contract will be awarded on a lowest-price technically acceptable basis to establish a pharmaceutical supply agreement serving the VA, Department of Defense, Bureau of Prisons, and Indian Health Service. Key requirements include submission of a Letter of Commitment if the offeror is not the manufacturer and compliance with specific packaging requirements including safety-cap bottles. The amendment to this solicitation extends the offer due date to November 25, 2025, at 2:30 PM Central Time, providing potential offerors additional time to prepare their proposals.

This solicitation is set aside for small businesses with a size standard of 1,300 employees. The contract structure includes a base year with four one-year option periods, with estimated annual usage quantities specified across the various line items and strengths to support multiple federal agencies. While no incumbent contractor is identified in the available documentation, the solicitation anticipates an effective contract date of October 31, 2025. No specific budget or award value is disclosed in the solicitation materials. The contract will be administered by the VA National Acquisition Center located in Hines, Illinois, with all pharmaceutical products to be supplied in compliance with federal regulations and specifications outlined in the solicitation documents.

Notice text

2 versions

Update #2 · Latest ·

Amendment to extend the due date of offers to 11/25/2025, 2:30PM CT.

Update #1 ·

N/A

Files

File Type Posted
36E79725R0066 0001.docx DOCX document
36E79725R0066_1.docx DOCX document

Notice history

Notice Type Posted
6505--Simvastatin Tablets (VA-26-00009813) Award Award Notice
This notice Latest solicitation Solicitation
6505--Simvastatin Tablets (VA-26-00009813) Original Pre-Solicitation

Similar open opportunities

Opportunity Agency Set-aside Responses due
6505--Imatinib Tablets NAICS 325412 National Acquisition Center No set-aside
6505--Sacubitril/Valsartan Tablets (VA-27-00014055) NAICS 325412 National Acquisition Center No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity